FAP-positive CAFs inhibit T cell infiltration into the tumor through CXCL12, and depletion of these fibroblasts or targeting of CXCL12 increases the sensitivity to immune checkpoint blockade of PC in preclinical models (38). Here, CXCL12 is linked to neoplasm.